• Hill-Rom
  • Hill-Rom 900 Accella
  • Mortara
  • Bariatric Care
  • Hill-Rom Declares Fiscal 2019 Third Quarter Dividend

    CHICAGO, May 8, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), announced today that its board of directors declared a fiscal 2019 third quarter dividend of $0.21 per share payable on June 28, 2019, to shareholders of record as of the close of business on June 21, 2019. The indicated annual dividend rate is $0.84 per share.

    Hill-Rom Announces Appointment Of Gregory Moore To Board Of Directors

    CHICAGO, May 7, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), announced the appointment of Gregory J. Moore MD, PhD, to its Board of Directors, effective May 7, 2019. Dr. Moore is currently the Corporate Vice President, Health Technology and Alliances at Microsoft Corporation.

    Hill-Rom to Present at the UBS 2019 Global Healthcare Conference

    CHICAGO, May 6, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), announced today that it will present at the UBS 2019 Global Healthcare Conference on Monday, May 20, 2019, in New York.   John Groetelaars, Hill-Rom's president and chief executive officer, is scheduled to present at 11:00 a.m. Eastern Time.

    Hill-Rom to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

    CHICAGO, April 30, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), announced today that John Groetelaars, president and CEO, will present at the Bank of America Merrill Lynch 2019 Healthcare Conference on Tuesday, May 14, 2019, at 11:20 a.m. Pacific Time in Las Vegas.

    Hill-Rom Reports Fiscal Second Quarter Financial Results

    CHICAGO, April 26, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), today announced financial results for the fiscal second quarter ended March 31, 2019, and updated its fiscal 2019 financial outlook.

    Hill-Rom Devices Earn U.S. Department of Defense Authority to Operate

    CHICAGO, April 23, 2019 - Hill-Rom (NYSE: HRC), a global medical technology company, today announced the U.S. Department of Defense (DoD) has granted Conditional Authority to Operate (ATO-C) to the company's Welch Allyn® Connex® monitoring systems (Connex Spot Monitor and Connex Vital Signs Monitor), Connex® vital signs connectivity solutions, and the ELI™ 380 resting ECG (electrocardiograph) device. The DoD authorization allows these Hill-Rom vital signs monitoring systems and resting ECG devices to be connected to DoD healthcare system networks in the U.S. and internationally.